Research Study

A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Principal Investigator 
Farzin Forooghian

Overview

Body Locations and Systems 
Uveitis
Health Conditions 
Uveitis
ClinicalTrials.gov# 
NCT01148225
Status 
Closed to Recruitment
Study Start/End 
Jan 5, 2012 to Jul 16, 2016
Locations 
Vancouver General Hospital
Name/Title 
Aleksandra Kuzmanovic, Clinical Trial Coordinator
Phone 
604-875-4253
Purpose of Study 

The objective of this study is to evaluate the long term efficacy and safety of adalimumab subjects with non-infectious intermediate-, posterior- or pan-uveitis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.